GlobeNewswire by notified

Interim report - Third quarter of 2022 - SP Group A/S

Share

SP Group generated revenue of DKK 2,007.5 million in the 9M 2022 reporting period, a 9.2% improvement from DKK 1,838.8 million in 9M 2021. EBITDA was up by 11.9% to DKK 354.4 million from DKK 316.8 million last year, and profit before tax was up by 5.5% to DKK 202.9 million. FY 2022 guidance is maintained. SP Group expects FY 2022 revenue to grow by 5-15% for an EBITDA margin of 16-18% and an EBT margin of 9-12%. The Board of Directors of SP Group A/S has today considered and approved the interim report for 9M 2022. Highlights of the interim report:

  • 9M 2022 revenue was up by DKK 168.7 million to DKK 2,007.5 million, for a 9.2% year-on-year increase. Company acquisitions added DKK 48.1 million to consolidated revenue. Q3 revenue grew by 1.1%.
  • Earnings before depreciation, amortisation and impairment losses (EBITDA) for the 9M 2022 period were DKK 354.4 million, against DKK 316.8 million in 9M 2021. Company acquisitions added DKK 15.6 million to EBITDA. External due diligence costs related to the acquisitions of DAVINCI 3D A/S and Bovil ApS reduced EBITDA by DKK 0.6 million. EBITDA declined by DKK 1.6 million in Q3 2022, for a 1.6% year-on-year decrease.
  • Depreciation, amortisation and impairment losses amounted to DKK 133.7 million, an increase of DKK 20.1 million relative to 9M 2021. Amortisation and depreciation in company acquisitions accounted for DKK 4.8 million of the increase.
  • Profit before net financials (EBIT) came to DKK 220.7 million in 9M 2022, for an 8.6% increase from DKK 203.2 million in 9M 2021. The Q3 EBIT was DKK 58.9 million against DKK 67.4 million in Q3 2021.
  • Net financials were an expense of DKK 17.8 million, a DKK 6.9 million increase relative to 9M 2021 that was due to negative value adjustments, higher interest rates and servicing of a larger debt.
  • Profit before tax was DKK 202.9 million in 9M 2022, a 5.5% improvement from DKK 192.4 million in 9M 2021. The Q3 EBT was DKK 49.4 million against DKK 62.9 million in Q3 2021.
  • Earnings per share (diluted) were up by 7.2% to DKK 13.12 in 9M 2022 from DKK 12.24 for the 9M 2021 period.
  • Sales of our own brands were up by 13.3% in 9M 2022 to DKK 541.8 million. At 27.0% of 9M 2022 revenue, SP Group’s own brands account for a growing proportion of revenue. Sales of our own brands were down by 6.5% in the third quarter to DKK 150.8 million.
  • Sales to the healthcare, food-related, automotive and other demanding industries increased during the reporting period, whereas cleantech sales declined.
  • There was a cash inflow from operating activities of DKK 210.2 million in 9M 2022, against a DKK 197.7 million inflow in 9M 2021. 
  • Net interest-bearing debt (NIBD) amounted to DKK 901.5 million at 30 September 2022, against DKK 753.8 million at 30 September 2021 and DKK 822.0 at 31 December 2021. NIBD was 2.0 times LTM EBITDA. NIBD increased by DKK 79.5 million in the 9M 2022 period, mainly due to the acquisitions of DAVINCI 3D A/S and Bovil ApS.
  • SP Group expects FY 2022 revenue to grow by 5-15% for an EBITDA margin of 16-18% and an EBT margin of 9-12%. However, due to rising energy prices, the war in Ukraine, the continuing spread of COVID-19 and the actions taken by the authorities combined with global bottleneck issues in a number of supply chains, our levels of activity and cash flows over the coming months are subject to considerable uncertainty. 

Statement by CEO Frank Gad: “We successfully delivered growth in revenue and EBITDA in the first nine months of 2022 despite rising energy prices, the war in Ukraine, global turbulence, many market challenges, volatile prices of raw materials and the COVID-19 pandemic. Nevertheless, we’re facing many challenges in a rapidly changing world. All of our 32 plants are operating and have access to the raw materials they need, and all our sales offices are open for business. We have benefited from our exposure to relatively resilient industries, and we have grown our sales to the healthcare, food-related and other demanding industries. We have continued to pursue our dedicated M&A strategy, thereby attracting more customers and getting access to new technology, and we’re committed to retaining our role as industry consolidators as and when value-adding opportunities arise.”

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Correction to Company announcement – No. 23 / 202419.4.2024 22:20:51 CEST | Press release

Correction to Company announcement – No. 23 / 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has a correction to company announcement No. 23 /2024, April 19, 2024 - regarding transactions in Zealand’s shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons it was reported that member of the management, Henriette Wennicke, was allocated a total of 8,008 restricted stock units with a total value of DKK 9,577,568.00. The correct number was a total of 8,008 restricted stock units with a total value of DKK 4,788,784.00. Please see the attached file(s). # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10

Nokia Corporation: Repurchase of own shares on 19.04.202419.4.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 19 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 19.04.2024 Espoo, Finland – On 19 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL430,8933.30CEUX--BATE--AQEU--TQEX--Total430,8933.30 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of

Landsbankinn hf.: Results of the 2024 AGM of Landsbankinn19.4.2024 20:48:08 CEST | Press release

The annual general meeting (AGM) of Landsbankinn, held on 19 April 2024, agreed to pay a dividend amounting to ISK 16,535 million to shareholders. The dividend is equivalent to 50% of 2023 profits. The dividend will be paid in two instalments, firstly on 24 April 2024 and secondly on 16 October 2024. As a result, total dividend paid by the Bank in 2013-2024 amounts to ISK 191.7 billion. At the AGM, held in Reykjastræti 6, Helga Björk Eiríksdóttir, Chairman of the Board of Directors, delivered the report from the Board for 2023. Lilja Björk Einarsdóttir, CEO, spoke of the Bank’s operation, strategy and activities in the past operating year. The annual financial statement for the past operating year was approved, as was the proposed Remuneration Policy and remuneration to Directors of the Board. The AGM elected the Auditor General (Ríkisendurskoðun) as auditor of Landsbankinn hf. for the 2024 operating year. The Auditor General, in accordance with an authorisation to outsource tasks, and

SKEL fjárfestingafélag hf.: Styrkás finalizes the purchase of Stólpi Gámar ehf. and affiliated companies.19.4.2024 19:20:57 CEST | Press release

Reference is made to the announcement dated 31 January 2024, regarding Styrkás hf., a company 69.64% owned by SKEL fjárfestingafélag hf., signing a purchase agreement to acquire 100% of the shares in six subsidiaries of Máttarstólpi ehf. The purchase agreement was subject to the approval of the Competition Authority. The transaction was finalized today with payment of purchase price and delivering of shares in the following companies: - Stólpi Gámar ehf., id. 460121-1590, Klettagörðum 5, 104 Reykjavík: - Stólpi Smiðja ehf., id. 460121-1750, Klettagörðum 5, 104 Reykjavík; - Klettskjól ehf., id. 460121-0510, Klettagörðum 5, 104 Reykjavík; - Stólpi ehf., 460121-0430, Klettagörðum 5, 104 Reykjavík; - Tjónaþjónustan ehf., id. 460121-1670, Klettagörðum 5, 104 Reykjavík; - Alkul ehf., id. 491020-0830, Haukdælabraut 48, 113 Reykjavík. collectively referred to as "the sold companies". These companies will continue to be operated on a consolidated basis. The Enterprise value of the sold companie

HiddenA line styled icon from Orion Icon Library.Eye